Cargando…

Targeting Amino Acid Metabolic Vulnerabilities in Myeloid Malignancies

Tumor cells require a higher supply of nutrients for growth and proliferation than normal cells. It is well established that metabolic reprograming in cancers for increased nutrient supply exposes a host of targetable vulnerabilities. In this article we review the documented changes in expression pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fultang, Livingstone, Gneo, Luciana, De Santo, Carmela, Mussai, Francis J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174708/ https://www.ncbi.nlm.nih.gov/pubmed/34094976 http://dx.doi.org/10.3389/fonc.2021.674720

Ejemplares similares

TGF-β orchestrates the phenotype and function of monocytic myeloid-derived suppressor cells in colorectal cancer
por: Gneo, Luciana, et al.
Publicado: (2021)

Engineering amino acid uptake or catabolism promotes CAR T-cell adaption to the tumor environment
por: Panetti, Silvia, et al.
Publicado: (2022)

Invariant NKT cells metabolically adapt to the acute myeloid leukaemia environment
por: Stavrou, Victoria, et al.
Publicado: (2022)

Amino Acid Metabolic Vulnerabilities in Acute and Chronic Myeloid Leukemias
por: Bhingarkar, Aboli, et al.
Publicado: (2021)

Targeting the arginine metabolic brake enhances immunotherapy for leukaemia
por: Mussai, Francis, et al.
Publicado: (2019)

MDSC targeting with Gemtuzumab ozogamicin restores T cell immunity and immunotherapy against cancers
por: Fultang, Livingstone, et al.
Publicado: (2019)

G‐CSF induces CD15(+) CD14(+) cells from granulocytes early in the physiological environment of pregnancy and the cancer immunosuppressive microenvironment
por: Maneta, Ebtehag, et al.
Publicado: (2022)

Challenges of Clinical Trial Design for Targeted Agents Against Pediatric Leukemias
por: Mussai, Francis Jay, et al.
Publicado: (2015)

Harnessing the Metabolic Vulnerabilities of Leukemia Stem Cells to Eradicate Acute Myeloid Leukemia
por: Kumar, Bijender
Publicado: (2021)

Metabolic therapy with PEG-arginase induces a sustained complete remission in immunotherapy-resistant melanoma
por: De Santo, Carmela, et al.
Publicado: (2018)

Myeloid-Derived Suppressor Cells as Therapeutic Target in Hematological Malignancies
por: De Veirman, Kim, et al.
Publicado: (2014)

Interactions Between Pseudomonas Immunotoxins and the Plasma Membrane: Implications for CAT-8015 Immunotoxin Therapy
por: Bokori-Brown, Monika, et al.
Publicado: (2018)

Integrated nontargeted and targeted metabolomics analyses amino acids metabolism in infantile hemangioma
por: Yang, Kaiying, et al.
Publicado: (2023)

Arginine auxotrophic gene signature in paediatric sarcomas and brain tumours provides a viable target for arginine depletion therapies
por: Vardon, Ashley, et al.
Publicado: (2017)

The Central Role of Amino Acids in Cancer Redox Homeostasis: Vulnerability Points of the Cancer Redox Code
por: Vučetić, Milica, et al.
Publicado: (2017)

Amino acid metabolism in primary bone sarcomas
por: Jiménez, Jennifer A., et al.
Publicado: (2022)

Shutting off the fuel supply to target metabolic vulnerabilities in multiple myeloma
por: Rana, Priyanka S., et al.
Publicado: (2023)

Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies
por: Chao, Mark P., et al.
Publicado: (2020)

Amino acid metabolic reprogramming in tumor metastatic colonization
por: Wang, Zihao, et al.
Publicado: (2023)

Modeling Myeloid Malignancies Using Zebrafish
por: Potts, Kathryn S., et al.
Publicado: (2017)

Amino Acid Transport and Metabolism in Myeloid Function
por: Halaby, Marie Jo, et al.
Publicado: (2021)

Targeting chemoresistance and mitochondria-dependent metabolic reprogramming in acute myeloid leukemia
por: Feng, Lili, et al.
Publicado: (2023)

Long Non-coding RNAs in Myeloid Malignancies
por: Zimta, Alina-Andreea, et al.
Publicado: (2019)

Recent Progress in Interferon Therapy for Myeloid Malignancies
por: Healy, Fiona M., et al.
Publicado: (2021)

Reprogramming of Amino Acid Metabolism in Pancreatic Cancer: Recent Advances and Therapeutic Strategies
por: Xu, Ruiyuan, et al.
Publicado: (2020)

Crosstalk between arginine, glutamine, and the branched chain amino acid metabolism in the tumor microenvironment
por: Wetzel, Tanner J., et al.
Publicado: (2023)

MicroRNA, an Antisense RNA, in Sensing Myeloid Malignancies
por: Setijono, Stephanie Rebecca, et al.
Publicado: (2018)

Liquid biopsies and minimal residual disease in myeloid malignancies
por: Allam, Sabine, et al.
Publicado: (2023)

CBMS-1 Targeting amino acid metabolic vulnerabilities in IDH-mutant and IDH-wildtype gliomas
por: Ohba, Shigeo, et al.
Publicado: (2021)

Regulation of Extracellular Matrix Production in Activated Fibroblasts: Roles of Amino Acid Metabolism in Collagen Synthesis
por: Kay, Emily J., et al.
Publicado: (2021)

Therapeutic Landscape of Malignant Pleural Mesothelioma: Collateral Vulnerabilities and Evolutionary Dependencies in the Spotlight
por: Xu, Duo, et al.
Publicado: (2020)

Rationale for Targeting Deregulated Metabolic Pathways as a Therapeutic Strategy in Acute Myeloid Leukemia
por: Chapuis, Nicolas, et al.
Publicado: (2019)

Integrated Non-targeted and Targeted Metabolomics Uncovers Amino Acid Markers of Oral Squamous Cell Carcinoma
por: Yang, Xi-Hu, et al.
Publicado: (2020)

Granulocyte Colony-Stimulating Factor Receptor Mutations in Myeloid Malignancy
por: Liongue, Clifford, et al.
Publicado: (2014)

Fatty acid metabolism predicts prognosis and NK cell immunosurveillance of acute myeloid leukemia patients
por: Ye, Zhitao, et al.
Publicado: (2022)

Targeting metabolic vulnerabilities to overcome resistance to therapy in acute myeloid leukemia
por: Sharma, Priyanka, et al.
Publicado: (2023)

The kynurenine pathway presents multi-faceted metabolic vulnerabilities in cancer
por: León-Letelier, Ricardo A., et al.
Publicado: (2023)

Arginine dependency is a therapeutically exploitable vulnerability in chronic myeloid leukaemic stem cells
por: Rattigan, Kevin M, et al.
Publicado: (2023)

Adult-onset hereditary myeloid malignancy and allogeneic stem cell transplantation
por: Toya, Takashi, et al.
Publicado: (2022)

LSD1 inhibition modulates transcription factor networks in myeloid malignancies
por: Hartung, Emily E., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nlemtam6dg9ng5pq907ndf39t3